Diethylcarbamazine (Dec) Tablet

Form: Tablets

Strength: 100 mg

Reference Brands: Generic formulations available in various generic brands

Category: Anthelmintic

Diethylcarbamazine (DEC) tablets, marketed as Eletcroos and generics, are approved in the US by the FDA and in the EU via EMA for treating lymphatic filariasis and tropical parasitic infections. Regulatory approval requires dossiers including clinical efficacy, safety data, manufacturing standards, and pharmacovigilance plans. In the US, clinical trial and quality data review facilitate approval, while the EMA ensures compliance with regional safety and manufacturing standards. For guidance on dossier preparation, regulatory pathways, and market access, visit PharmaTradz. Proper adherence supports timely approval, safe use, and global availability, aiding in parasite control and disease prevention worldwide.